BACKGROUND: Non-small cell lung cancer (NSCLC) is one of the causes of carcinomas mortality worldwide. Ecliptasaponin A (ES), a natural product extracted from the plant known as Eclipta prostrata, has been reported as an anti-cancer drug against various cancer cell lines. However, the exact mechanisms of ES have not yet been fully characterized. METHODS: Numerous studies have been done to support that ES has a powerful inhibiting effect on the growth of cancers via the activation of apoptosis and autophagy. To explore the underlying mechanisms of anti-cancer and investigate the relationships of the apoptosis and autophagy, we used apoptosis signal-regulating kinase 1 (ASK1) inhibitor (GS-4997), c-Jun N-terminal kinase (JNK) inhibitor (SP600125), and autophagy inhibitor [chloroquine (CQ) and 3-methyladenine (3-MA)]. RESULTS: ES could potently suppress cell viability and induces apoptotic cell death of human lung cancer cells H460 and H1975. ES activated apoptosis via ASK1/JNK pathway, GS-4997 and SP600125 can attenuated these effects. Furthermore, ES could triggered autophagy in lung cancer cell lines, and the autophagy inhibitor 3-MA and CQ reversed ES-induced apoptosis in H460 and H1975 cells. Furthermore, SP600125 can inhibit autophagy. CONCLUSIONS: This study showed that ES induces apoptosis in human lung cancer cells by triggering enhanced autophagy and ASK1/JNK pathway, which may thus be a promising agent against lung cancer. 2019 Annals of Translational Medicine. All rights reserved.
BACKGROUND: Non-small cell lung cancer (NSCLC) is one of the causes of carcinomas mortality worldwide. Ecliptasaponin A (ES), a natural product extracted from the plant known as Eclipta prostrata, has been reported as an anti-cancer drug against various cancer cell lines. However, the exact mechanisms of ES have not yet been fully characterized. METHODS: Numerous studies have been done to support that ES has a powerful inhibiting effect on the growth of cancers via the activation of apoptosis and autophagy. To explore the underlying mechanisms of anti-cancer and investigate the relationships of the apoptosis and autophagy, we used apoptosis signal-regulating kinase 1 (ASK1) inhibitor (GS-4997), c-Jun N-terminal kinase (JNK) inhibitor (SP600125), and autophagy inhibitor [chloroquine (CQ) and 3-methyladenine (3-MA)]. RESULTS: ES could potently suppress cell viability and induces apoptotic cell death of human lung cancer cells H460 and H1975. ES activated apoptosis via ASK1/JNK pathway, GS-4997 and SP600125 can attenuated these effects. Furthermore, ES could triggered autophagy in lung cancer cell lines, and the autophagy inhibitor 3-MA and CQ reversed ES-induced apoptosis in H460 and H1975 cells. Furthermore, SP600125 can inhibit autophagy. CONCLUSIONS: This study showed that ES induces apoptosis in human lung cancer cells by triggering enhanced autophagy and ASK1/JNK pathway, which may thus be a promising agent against lung cancer. 2019 Annals of Translational Medicine. All rights reserved.
Authors: Detian Yuan; Shan Huang; Emanuel Berger; Lei Liu; Nina Gross; Florian Heinzmann; Marc Ringelhan; Tracy O Connor; Mira Stadler; Michael Meister; Julia Weber; Rupert Öllinger; Nicole Simonavicius; Florian Reisinger; Daniel Hartmann; Rüdiger Meyer; Maria Reich; Marco Seehawer; Valentina Leone; Bastian Höchst; Dirk Wohlleber; Simone Jörs; Marco Prinz; Duncan Spalding; Ulrike Protzer; Tom Luedde; Luigi Terracciano; Matthias Matter; Thomas Longerich; Percy Knolle; Thomas Ried; Verena Keitel; Fabian Geisler; Kristian Unger; Einat Cinnamon; Eli Pikarsky; Norbert Hüser; Roger J Davis; Darjus F Tschaharganeh; Roland Rad; Achim Weber; Lars Zender; Dirk Haller; Mathias Heikenwalder Journal: Cancer Cell Date: 2017-06-12 Impact factor: 31.743
Authors: H Ichijo; E Nishida; K Irie; P ten Dijke; M Saitoh; T Moriguchi; M Takagi; K Matsumoto; K Miyazono; Y Gotoh Journal: Science Date: 1997-01-03 Impact factor: 47.728
Authors: Daniel J de Klerk; Mark J de Keijzer; Lionel M Dias; Jordi Heemskerk; Lianne R de Haan; Tony G Kleijn; Leonardo P Franchi; Michal Heger Journal: Methods Mol Biol Date: 2022